i
Loading Page
loading, please wait

Select Year:

Home > PA Providers
placeholder image of provider

Dr. Lee M. Blatstein, DO

Accepting New Patients
Specializes in: Urologic Oncology
Penn State College of Medicine (1984)
Professional interests include: robotic prostatectomy, vasectomy, urologic (genitourinary) disorders, and more.
125 MEDICAL CAMPUS DRIVE SUITE 305
LANSDALE, PA 19446

Dr. Lee M. Blatstein, DO is an urologic oncologist in LANSDALE, PA specializing in urologic oncology. He graduated from Penn State College of Medicine in 1984 and has 42 years of experience. Dr. Lee M. Blatstein, DO is affiliated with Abington Hospital - Jefferson Health, Jefferson Health and Jefferson Lansdale Hospital.

View Doctor's Full Profile (215) 361-2304

Office Locations

125 MEDICAL CAMPUS DRIVE SUITE 305
LANSDALE, PA 19446
(215) 361-2304
(215) 361-2389
open_in_new

Some issues Dr. Lee M. Blatstein, DO can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

  • Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
  • Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
  • Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
  • Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

  • Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
  • Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
  • Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

Shock Wave Lithotripsy

Stones are formed when mineral deposits build up and harden in an organ or gland. For example, urine contains minerals that can form crystals and result in kidney or bladder stones. Stones can also occur in other parts of the body, like the mouth. Salivary gland stones form when the chemicals in the saliva harden and get stuck in the tiny ducts of the salivary glands. Pain and swelling are the most common symptoms associated with stones.

Lithotripsy is a procedure used to break up small stones. Shock wave lithotripsy, the most common type of lithotripsy and least invasive way of treating stones, does this using high-powered sound waves. This procedure can treat many types of stones in the body, but it is most frequently used for urinary stones, such as kidney and bladder stones.

Shock wave lithotripsy can be done in one of two ways. Conventionally, this procedure is performed when someone is sitting in a tub of water, and the sound waves travel through the water to their body. A more recent alternative is to send the shock waves through cushions while a patient is lying on a table. Although shock wave lithotripsy is not surgery and requires no cutting, the patient will be given anesthesia before the procedure. Their body should be able to pass the broken-up urinary stones naturally in their urine after treatment. For other types of stones, another minimally invasive procedure may be required to remove stone fragments left by shock wave lithotripsy.

Noteworthy Medicare Patient Procedures Performed by Dr. Lee M. Blatstein, DO in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

biopsy
core needle prostate biopsy
diagnostic cystoscopy
prostate biopsy
prostate punch biopsy
shock wave lithotripsy
urologic procedures

By Affordability:

shock wave lithotripsy

In 2023, among providers in related specialties within Pennsylvania, Dr. Lee M. Blatstein, DO performed more biopsy, core needle prostate biopsy, diagnostic cystoscopy, prostate biopsy, prostate punch biopsy, shock wave lithotripsy, and urologic procedures procedures for Medicare patients than 95% of them and he also had a list price for shock wave lithotripsy that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Volume:

minimally invasive procedures
post void residual study
urinalysis

In 2023, Dr. Lee M. Blatstein, DO performed more minimally invasive procedures, post void residual study, and urinalysis procedures for Medicare patients than 90% of providers in related specialties within Pennsylvania.

Top 25%

By Volume:

inpatient hospital care

By Affordability:

core needle prostate biopsy
cystoscopy
hospital care
inpatient care
inpatient hospital care
lab tests
post void residual study
prostate biopsy
prostate punch biopsy
urinalysis
urine tests

In 2012, among providers in related specialties within Pennsylvania, Dr. Lee M. Blatstein, DO performed more inpatient hospital care (for patient admitted to hospital) procedures for Medicare patients than 75% of them and he also had a list price for core needle prostate biopsy, cystoscopy, hospital care, inpatient care, inpatient hospital care (for patient admitted to hospital), lab tests, post void residual study, prostate biopsy, prostate punch biopsy, urinalysis, and urine tests that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2012 were lab tests, urologic procedures, inpatient care and hospital care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

ablation 13
catheterization 22
cytology 43
diagnostic procedures 19
doctor visit 1364
hormone therapy 59
hospital care 231
inpatient care 231
lab tests 1161
laser treatment 13
lithotripsy (stone fragmentation) 13
minimally invasive procedures 228
minor procedures 19
stent placement (stenting) 19
suprapubic catheter replacement 31
urologic procedures 681

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2013 were lab tests, urologic procedures, inpatient care and hospital care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

ablation 14
catheterization 64
cytology 45
diagnostic procedures 35
doctor visit 1694
hormone therapy 71
hospital care 315
inpatient care 315
lab tests 1383
laser treatment 14
lithotripsy (stone fragmentation) 27
minimally invasive procedures 293
minor procedures 35
stent placement (stenting) 27
suprapubic catheter replacement 20
urologic procedures 1028

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 820
Female 225
Ethnicity
Non-Hispanic White 957
Black 33
Hispanic 15
Asian 23
Other 17
Native American 0
Age
From 65 to 74 431
From 75 to 84 353
85 and over 199
Less than 65 62

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2013

Hypertension 74
High Cholesterol 69
Stroke 8
Ischemic Heart Disease 40
Depression 18
Chronic Kidney Disease 27
Asthma 6
Osteoperosis 7
Atrial Fibrilation 16
Heart Failure 20
Chronic Obstructive Pulmonary Disease 14
Diabetes 30
Dementia 12
Cancer 26

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2014 were lab tests, urologic procedures, inpatient care and hospital care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

ablation 12
catheterization 67
diagnostic procedures 46
doctor visit 1887
hormone therapy 73
hospital care 398
inpatient care 398
lab tests 1546
laser treatment 12
lithotripsy (stone fragmentation) 17
minimally invasive procedures 320
minor procedures 32
stent placement (stenting) 20
urologic procedures 1454

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 877
Female 237
Ethnicity
Non-Hispanic White 1017
Black 38
Hispanic 14
Asian 21
Other 24
Native American 0
Age
From 65 to 74 442
From 75 to 84 389
85 and over 212
Less than 65 71

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2014

Hypertension 74
High Cholesterol 68
Stroke 7
Ischemic Heart Disease 40
Depression 19
Chronic Kidney Disease 31
Asthma 5
Osteoperosis 5
Atrial Fibrilation 17
Heart Failure 19
Chronic Obstructive Pulmonary Disease 14
Diabetes 31
Dementia 13
Cancer 26

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2015 were lab tests, urologic procedures, hospital care and inpatient care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

catheterization 62
diagnostic procedures 24
doctor visit 1744
hormone therapy 66
hospital care 310
inpatient care 310
lab tests 1471
minimally invasive procedures 278
minor procedures 24
urologic procedures 1359

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 1692
Female 440
Ethnicity
Non-Hispanic White 1908
Black 92
Hispanic 22
Asian 62
Other 48
Native American 0
Age
From 65 to 74 898
From 75 to 84 696
85 and over 420
Less than 65 118

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2015

Hypertension 75
High Cholesterol 69
Stroke 9
Ischemic Heart Disease 38
Depression 19
Chronic Kidney Disease 31
Asthma 8
Osteoperosis 6
Atrial Fibrilation 16
Heart Failure 18
Chronic Obstructive Pulmonary Disease 12
Diabetes 30
Dementia 13
Cancer 26

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2016 were lab tests, urologic procedures, minimally invasive procedures and inpatient care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

catheterization 57
diagnostic procedures 48
doctor visit 2156
foreign body removal 14
hormone therapy 79
hospital care 342
inpatient care 342
lab tests 1823
lithotripsy (stone fragmentation) 20
minimally invasive procedures 350
minor procedures 30
potassium test 18
stent placement (stenting) 26
urologic procedures 1674

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 992
Female 271
Ethnicity
Non-Hispanic White 1143
Black 53
Hispanic 13
Asian 22
Other 32
Native American 0
Age
From 65 to 74 545
From 75 to 84 403
85 and over 241
Less than 65 74

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2016

Hypertension 74
High Cholesterol 67
Stroke 7
Ischemic Heart Disease 37
Depression 19
Chronic Kidney Disease 35
Asthma 15
Osteoperosis 6
Atrial Fibrilation 16
Heart Failure 16
Chronic Obstructive Pulmonary Disease 14
Diabetes 29
Dementia 14
Cancer 24

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2017 were lab tests, urologic procedures, minimally invasive procedures and inpatient care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

ablation 14
catheterization 68
diagnostic procedures 34
doctor visit 2135
hormone therapy 73
hospital care 288
inpatient care 288
lab tests 1787
laser treatment 14
lithotripsy (stone fragmentation) 28
minimally invasive procedures 293
minor procedures 34
placement of vaginal support device 16
stent placement (stenting) 16
urologic procedures 1671

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 980
Female 285
Ethnicity
Non-Hispanic White 1130
Black 48
Hispanic 16
Asian 36
Other 35
Native American 0
Age
From 65 to 74 543
From 75 to 84 433
85 and over 223
Less than 65 66

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2017

Hypertension 75
High Cholesterol 62
Stroke 8
Ischemic Heart Disease 37
Depression 21
Chronic Kidney Disease 38
Asthma 6
Osteoperosis 5
Atrial Fibrilation 16
Heart Failure 17
Chronic Obstructive Pulmonary Disease 15
Diabetes 31
Dementia 13
Cancer 24

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2018 were urologic procedures, lab tests, inpatient care and hospital care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

ablation 17
catheterization 16
diagnostic procedures 39
doctor visit 1397
hormone therapy 51
hospital care 299
inpatient care 299
lab tests 1139
laser treatment 17
lithotripsy (stone fragmentation) 19
minimally invasive procedures 265
minor procedures 39
potassium test 11
stent placement (stenting) 21
urologic procedures 1209

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 865
Female 118
Ethnicity
Non-Hispanic White 874
Black 39
Hispanic 0
Asian 32
Other 0
Native American 0
Age
From 65 to 74 443
From 75 to 84 348
85 and over 155
Less than 65 37

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2018

Hypertension 74
High Cholesterol 71
Stroke 8
Ischemic Heart Disease 37
Depression 19
Chronic Kidney Disease 41
Asthma 5
Osteoperosis 4
Atrial Fibrilation 18
Heart Failure 16
Chronic Obstructive Pulmonary Disease 12
Diabetes 31
Dementia 13
Cancer 25

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2019 were urologic procedures, lab tests, minimally invasive procedures and hospital care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

ablation 16
diagnostic procedures 35
doctor visit 1364
hormone therapy 58
hospital care 224
inpatient care 224
lab tests 1130
laser treatment 16
minimally invasive procedures 236
minor procedures 35
stent placement (stenting) 17
urologic procedures 1155

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 816
Female 115
Ethnicity
Non-Hispanic White 831
Black 0
Hispanic 0
Asian 28
Other 38
Native American 0
Age
From 65 to 74 417
From 75 to 84 334
85 and over 150
Less than 65 30

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2019

Hypertension 74
High Cholesterol 73
Stroke 7
Ischemic Heart Disease 37
Depression 21
Chronic Kidney Disease 42
Asthma 7
Osteoperosis 4
Atrial Fibrilation 20
Heart Failure 18
Chronic Obstructive Pulmonary Disease 13
Diabetes 28
Dementia 14
Cancer 27

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2020 were urologic procedures, lab tests, hospital care and inpatient care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

diagnostic procedures 44
doctor visit 1037
hormone therapy 49
hospital care 201
inpatient care 201
lab tests 623
minimally invasive procedures 152
minor procedures 44
urologic procedures 685

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 718
Female 83
Ethnicity
Non-Hispanic White 713
Black 30
Hispanic 0
Asian 0
Other 38
Native American 0
Age
From 65 to 74 358
From 75 to 84 318
85 and over 102
Less than 65 23

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2020

Hypertension 72
High Cholesterol 70
Stroke 7
Ischemic Heart Disease 39
Depression 19
Chronic Kidney Disease 42
Asthma 6
Osteoperosis 3
Atrial Fibrilation 17
Heart Failure 18
Chronic Obstructive Pulmonary Disease 13
Diabetes 27
Dementia 11
Cancer 29

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2021 were urologic procedures, lab tests, hospital care and inpatient care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

diagnostic procedures 25
doctor visit 971
hormone therapy 39
hospital care 188
inpatient care 188
lab tests 426
lithotripsy (stone fragmentation) 14
minimally invasive procedures 137
minor procedures 25
urologic procedures 711

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 742
Female 98
Ethnicity
Non-Hispanic White 747
Black 25
Hispanic 0
Asian 0
Other 42
Native American 0
Age
From 65 to 74 363
From 75 to 84 339
85 and over 116
Less than 65 22

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2021

Hypertension 75
High Cholesterol 71
Stroke 7
Ischemic Heart Disease 39
Depression 18
Chronic Kidney Disease 44
Asthma 5
Osteoperosis 3
Atrial Fibrilation 17
Heart Failure 18
Chronic Obstructive Pulmonary Disease 9
Diabetes 28
Dementia 11
Cancer 27

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA during 2022 were urologic procedures, lab tests, hospital care and inpatient care.

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

diagnostic procedures 56
doctor visit 1144
hormone therapy 24
hospital care 208
inpatient care 208
lab tests 721
lithotripsy (stone fragmentation) 14
minimally invasive procedures 183
minor procedures 44
urologic procedures 776

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 850
Female 126
Ethnicity
Non-Hispanic White 862
Black 32
Hispanic 0
Asian 0
Other 49
Native American 0
Age
From 65 to 74 402
From 75 to 84 406
85 and over 138
Less than 65 30

Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO in 2022

Hypertension 75
High Cholesterol 75
Stroke 10
Ischemic Heart Disease 32
Depression 18
Chronic Kidney Disease 31
Asthma 7
Osteoperosis 6
Atrial Fibrilation 23
Heart Failure 15
Chronic Obstructive Pulmonary Disease 13
Diabetes 26
Dementia 8
Cancer 29

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Lee M. Blatstein, DO for Medicare patients.

The highest averages for the top procedures that Dr. Lee M. Blatstein, DO treated as an urologic oncologist in LANSDALE, PA were lab tests, urologic procedures, inpatient care and hospital care.

ablation 14
catheterization 50
cytology 44
diagnostic procedures 36
doctor visit 1535
foreign body removal 14
hormone therapy 58
hospital care 273
inpatient care 273
lab tests 1200
laser treatment 14
lithotripsy (stone fragmentation) 19
minimally invasive procedures 248
minor procedures 32
potassium test 14
stent placement (stenting) 20
urologic procedures 1127

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Lee M. Blatstein, DO.

Gender
Male 850
Female 181
Ethnicity
Black / African American 35
Asian / Pacific Islander 20
Non-Hispanic White 925
Hispanic 7
Native American / Alaskan Native 0
Other 29
Age
75 to 84 365
85 and over 177
Less than 65 48
65 to 74 440

Average of Total of Conditions of Medicare patients treated by Dr. Lee M. Blatstein, DO From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Lee M. Blatstein, DO treated were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.

Hypertension 67
High Cholesterol 63
Stroke 7
Ischemic Heart Disease 34
Depression 17
Chronic Kidney Disease 32
Asthma 6
Osteoporosis 4
Heart Failure 15
Chronic Obstructive Pulmonary Disease 11
Diabetes 26
Atrial Fibrillation 16
Cancer 23
Dementia 11

Education & Training

Dr. Lee M. Blatstein, DO graduated from Penn State College of Medicine in 1984. He completed residency at Philadelphia College of Osteopathic Medicine Affiliated Hospitals. He is certified by the Board Certification: Urology and has a state license in Pennsylvania.

Medical School: Penn State College of Medicine (1984)

Residency: Philadelphia College of Osteopathic Medicine Affiliated Hospitals

Board Certification: Board Certification: Urology

Licensed In: Pennsylvania

Affiliations & Hospitals

Dr. Lee M. Blatstein, DO is associated with these hospitals and organizations:

Abington Hospital - Jefferson Health
Jefferson Health
Jefferson Lansdale Hospital

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Lee M. Blatstein, DO appears to accept the following insurance providers: United Healthcare Community Plan (AmeriChoice), QualCare, Aetna Medicare, Highmark Blue Cross Blue Shield, CIGNA Medicare, Blue Cross Federal, Horizon Blue Cross Blue Shield, GEHA, WellCare, AmeriHealth, AARP, MultiPlan, CIGNA Commercial, Geisinger Health Plan, US Family Health Plan, United Healthcare, Medicaid, Humana, Workers' Compensation, Cigna, Devon Health, TRICARE, First Health, WellPoint, Jefferson Health Plans (Medicare & ACA), Medical Assistance of New Jersey, Provider Partners Medicare, PA Health and Wellness CHC, Devoted Medicare, Medical Assistance of Delaware, Keystone First/CHC/VIP, Blue Card by BCBS, Medicare FFS, Medical Assistance of Pennsylvania, Independence Blue Cross - Various plans, Aetna Commercial - Excludes Marketplace Plans, UPMC, Aetna Better Health CHIP PA, Highmark Wholecare, Ambetter from PA Health and Wellness and Keystone First VIP.

Insurance Accepted by Provider includes:

According to our sources, Dr. Lee M. Blatstein, DO accepts the following insurance providers:

United Healthcare Community Plan (AmeriChoice)
QualCare
Aetna Medicare
Highmark Blue Cross Blue Shield
CIGNA Medicare
Blue Cross Federal
Horizon Blue Cross Blue Shield
GEHA
WellCare
AmeriHealth
AARP
MultiPlan
CIGNA Commercial
Geisinger Health Plan
US Family Health Plan
United Healthcare
Medicaid
Humana
Workers' Compensation
Cigna
Devon Health
TRICARE
First Health
WellPoint
Jefferson Health Plans (Medicare & ACA)
Medical Assistance of New Jersey
Provider Partners Medicare
PA Health and Wellness CHC
Devoted Medicare
Medical Assistance of Delaware
Keystone First/CHC/VIP
Blue Card by BCBS
Medicare FFS
Medical Assistance of Pennsylvania
Independence Blue Cross - Various plans
Aetna Commercial - Excludes Marketplace Plans
UPMC
Aetna Better Health CHIP PA
Highmark Wholecare
Ambetter from PA Health and Wellness
Keystone First VIP

Ratings & Reviews

Dr. Lee M. Blatstein, DO has an exceptional overall rating with an average of 4.89 out of 5 stars based on 5591 ratings. We collect ratings and reviews of Dr. Lee M. Blatstein, DO from all over the web to help you find the right in LANSDALE, PA. 

4.89
Overall Rating
Leave a Review
Reviews Left On DocSpot
Overall Rating: 3.0 2021-12-22 
HAVE A PROBLEM - GROWTH ON GLANDS - CALLED WAS TOLD THE SOONEST TO SEE HIM IS MAY - PROBLEM "COULDN'T I BE SQUEZED IN?" SECOND TIME I WAS TOLD BEFORE TO FIND A NEW DOCTOR - I NEED A PRACTICE THAT CARES ABOUT THEIR PATIENTS - IT IS NOT HERE - GOODBYE(have been a patient 10 years or more)

General Payments

These charts describe general payments received by Dr. Lee M. Blatstein, DO. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Payments by Company
Astellas Pharma US Inc $2,054 Vesicare
$938 		Myrbetriq
$289 		XTANDI
$283
$544
Janssen Biotech, Inc. $703 Erleada
$412 		ZYTIGA
$271
$20
Northeast Cryotherapy LP $431 Cryo Probe
$431
UHS Surgical Services, Inc. $317 Urology Equipment
$154
$163
AbbVie, Inc. $275 Lupron
$99 		Androgel
$97 		Lupron Depot
$80
Other $3,247 Xofigo
$216 		Lupron Depot
$186 		Urolift - UL400
$165 		XGEVA
$157 		INTERSTIM
$151 		Other
$2,372
Types of Payments
Food and Beverage $5,829
Education $767
Current or prospective ownership or investment interest $431

Ownership and Interest Payments

This table describes ownership payments received by Dr. Lee M. Blatstein, DO.

Northeast Cryotherapy LP 2014 $201.91 Physician Covered Recipient Limited Partner Interest
Northeast Cryotherapy LP 2015 $196.39 Physician Covered Recipient Limited Partner Interest

Biography

Dr. Lee Blatstein's specialty is urologic oncology. His average rating from his patients is 5.0 stars (out of 5). His areas of expertise include bladder cancer, uroflowmetry, and shock wave lithotripsy. Dr. Blatstein is affiliated with Abington Hospital - Jefferson Health. He appears to be in-network for Blue California, Coventry, Geisinger Health Plan, and more. His practice in LANSDALE, PA is open to new patients as reported by Doctor.com. Dr. Blatstein obtained his medical school training at Philadelphia College of Osteopathic Medicine and Penn State College of Medicine and performed his residency at a hospital affiliated with MCP Hahnemann School of Medicine, Allegheny University and a hospital affiliated with Philadelphia College of Osteopathic Medicine.

Other Providers in LANSDALE, PA